AAAAAA

   
Results: 1-16 |
Results: 16
PHARMACOKINETICS AND PHARMACODYNAMICS OF ZOLMITRIPTAN IN PATIENTS WITH MILD-TO-MODERATE HYPERTENSION - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
Authors: SMITH DA CLEARY EW WATKINS S HUFFMAN CS DILZER SC LASSETER KC
Citation: Da. Smith et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF ZOLMITRIPTAN IN PATIENTS WITH MILD-TO-MODERATE HYPERTENSION - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY, Journal of clinical pharmacology, 38(8), 1998, pp. 685-693
PHARMACOKINETICS AND PHARMACODYNAMICS OF IRBESARTAN IN PATIENTS WITH HEPATIC CIRRHOSIS
Authors: MARINO MR LANGENBACHER KM RAYMOND RH FORD NF LASSETER KC
Citation: Mr. Marino et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF IRBESARTAN IN PATIENTS WITH HEPATIC CIRRHOSIS, Journal of clinical pharmacology, 38(4), 1998, pp. 347-356
POPULATION PHARMACOKINETICS AND PHARMACODYNAMICS OF PYRIDOSTIGMINE BROMIDE FOR PROPHYLAXIS AGAINST NERVE AGENTS IN HUMANS
Authors: MARINO MT SCHUSTER BG BRUECKNER RP LIN E KAMINSKIS A LASSETER KC
Citation: Mt. Marino et al., POPULATION PHARMACOKINETICS AND PHARMACODYNAMICS OF PYRIDOSTIGMINE BROMIDE FOR PROPHYLAXIS AGAINST NERVE AGENTS IN HUMANS, Journal of clinical pharmacology, 38(3), 1998, pp. 227-235
FIRST-TIME-IN-HUMANS SAFETY AND PHARMACOKINETICS OF WR-238605, A NEW ANTIMALARIAL
Authors: BRUECKNER RP LASSETER KC LIN ET SCHUSTER BG
Citation: Rp. Brueckner et al., FIRST-TIME-IN-HUMANS SAFETY AND PHARMACOKINETICS OF WR-238605, A NEW ANTIMALARIAL, The American journal of tropical medicine and hygiene, 58(5), 1998, pp. 645-649
EFFECT OF HYDROCHLOROTHIAZIDE ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ANGIOTENSIN-II BLOCKER IRBESARTAN
Authors: MARINO MR LANGENBACHER KM FORD NE BEIERLE F RAYMOND RH SHAMBLEN EC LASSETER KC
Citation: Mr. Marino et al., EFFECT OF HYDROCHLOROTHIAZIDE ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ANGIOTENSIN-II BLOCKER IRBESARTAN, Clinical drug investigation, 14(5), 1997, pp. 383-391
EVALUATION OF INDAPAMIDE 1.25 MG ONCE-DAILY IN ELDERLY PATIENTS WITH MILD-TO-MODERATE HYPERTENSION
Authors: FIDDES R BLUMENTHAL J DAWSON JE DYCKMAN E HAMMOND PGSJ HARRIS S LASSETER KC LEVINE BS MONTORO R NIEDERMAN AL RATNER PH ROSENBLATT S TOTH PD VERGIS J CODISPOTI J
Citation: R. Fiddes et al., EVALUATION OF INDAPAMIDE 1.25 MG ONCE-DAILY IN ELDERLY PATIENTS WITH MILD-TO-MODERATE HYPERTENSION, Journal of human hypertension, 11(4), 1997, pp. 239-244
METABOLIC PROFILES OF MONTELUKAST SODIUM (SINGULAR), A POTENT CYSTEINYL LEUKOTRIENE(1) RECEPTOR ANTAGONIST, IN HUMAN PLASMA AND BILE
Authors: BALANI SK XU X PRATHA V KOSS MA AMIN RD DUFRESNE C MILLER RR ARISON BH DOSS GA CHIBA M FREEMAN A HOLLAND SD SCHWARTZ JI LASSETER KC GERTZ BJ ISENBERG JI ROGERS JD LIN JH BAILLIE TA
Citation: Sk. Balani et al., METABOLIC PROFILES OF MONTELUKAST SODIUM (SINGULAR), A POTENT CYSTEINYL LEUKOTRIENE(1) RECEPTOR ANTAGONIST, IN HUMAN PLASMA AND BILE, Drug metabolism and disposition, 25(11), 1997, pp. 1282-1287
EFFECT OF HYDROCHLOROTHIAZIDE ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF IRBESARTAN
Authors: MARINO MR LANGENBACHER KM FORD NF BEIERLE F SHAMBLEN EC LASSETER KC
Citation: Mr. Marino et al., EFFECT OF HYDROCHLOROTHIAZIDE ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF IRBESARTAN, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 52-52
EFFECT OF MK-386, A NOVEL INHIBITOR OF TYPE-1 5-ALPHA-REDUCTASE, ALONE AND IN COMBINATION WITH FINASTERIDE, ON SERUM DIHYDROTESTOSTERONE CONCENTRATIONS IN MEN
Authors: SCHWARTZ JI VANHECKEN A DESCHEPPER PJ DELEPELEIRE I LASSETER KC SHAMBLEN EC WINCHELL GA CONSTANZER ML CHAVEZ CM WANG DZ EBEL DL JUSTICE SJ GERTZ BJ
Citation: Ji. Schwartz et al., EFFECT OF MK-386, A NOVEL INHIBITOR OF TYPE-1 5-ALPHA-REDUCTASE, ALONE AND IN COMBINATION WITH FINASTERIDE, ON SERUM DIHYDROTESTOSTERONE CONCENTRATIONS IN MEN, The Journal of clinical endocrinology and metabolism, 81(8), 1996, pp. 2942-2947
PHARMACOKINETIC PROFILE OF PILOCARPINE HYDROCHLORIDE IN SUBJECTS WITHIMPAIRED HEPATIC-FUNCTION
Authors: GARG DC LASSETER KC SHROTRIYA RC SHAMBLEN EC SHAMBLEN S HOFF JV GALLAGHER SC
Citation: Dc. Garg et al., PHARMACOKINETIC PROFILE OF PILOCARPINE HYDROCHLORIDE IN SUBJECTS WITHIMPAIRED HEPATIC-FUNCTION, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 48-48
SINGLE-DOSE AND STEADY-STATE PHARMACOKINETICS OF FOSINOPRIL AND FOSINOPRILAT IN PATIENTS WITH HEPATIC IMPAIRMENT
Authors: FORD NF LASSETER KC VANHARKEN DR HAMMETT JL RAYMOND R MANNING J
Citation: Nf. Ford et al., SINGLE-DOSE AND STEADY-STATE PHARMACOKINETICS OF FOSINOPRIL AND FOSINOPRILAT IN PATIENTS WITH HEPATIC IMPAIRMENT, Journal of clinical pharmacology, 35(2), 1995, pp. 145-150
STUDIES OF THE ORAL BIOAVAILABILITY OF ALENDRONATE
Authors: GERTZ BJ HOLLAND SH KLINE WF MATUSZEWSKI BK FREEMAN A QUAN H LASSETER KC MUCKLOW JC PORRAS AG
Citation: Bj. Gertz et al., STUDIES OF THE ORAL BIOAVAILABILITY OF ALENDRONATE, Clinical pharmacology and therapeutics, 58(3), 1995, pp. 288-298
THE BIOAVAILABILITY AND NONLINEAR PHARMACOKINETICS OF MK-679 IN HUMANS
Authors: CHENG HY SCHWARTZ JI LIN C AMIN RD SEIBOLD JR LASSETER KC EBEL DL TOCCO DJ ROGERS JD
Citation: Hy. Cheng et al., THE BIOAVAILABILITY AND NONLINEAR PHARMACOKINETICS OF MK-679 IN HUMANS, Biopharmaceutics & drug disposition, 15(5), 1994, pp. 409-418
PHARMACODYNAMICS OF MK-0963, A NEW 5-ALPHA-REDUCTASE INHIBITOR - EFFECTS ON SERUM ANDROGEN CONCENTRATIONS
Authors: SCHWARTZ JI LASKIN OL MEETER CA PATTERSON PM SCHNEIDER SH LASSETER KC SEIBOLD JR
Citation: Ji. Schwartz et al., PHARMACODYNAMICS OF MK-0963, A NEW 5-ALPHA-REDUCTASE INHIBITOR - EFFECTS ON SERUM ANDROGEN CONCENTRATIONS, Clinical pharmacology and therapeutics, 55(1), 1994, pp. 50-54
PHARMACODYNAMICS AND DOSE-RESPONSE RELATIONSHIP OF FAMOTIDINE - A DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED TRIAL
Authors: LASKIN OL PATTERSON PM SHINGO S LASSETER KC SHAMBLEN EC
Citation: Ol. Laskin et al., PHARMACODYNAMICS AND DOSE-RESPONSE RELATIONSHIP OF FAMOTIDINE - A DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED TRIAL, Journal of clinical pharmacology, 33(7), 1993, pp. 636-639
COMPARATIVE ABSORPTION OF ATROPINE FROM A METERED-DOSE INHALER AND ANINTRAMUSCULAR INJECTION
Authors: KEHE CR LASSETER KC MILLER NC WICK KA SHAMBLEN EC EKHOLM BP SANDAHL JH CHANG SF GOLDLUST MB KVAM DC HARRISON LI
Citation: Cr. Kehe et al., COMPARATIVE ABSORPTION OF ATROPINE FROM A METERED-DOSE INHALER AND ANINTRAMUSCULAR INJECTION, Therapeutic drug monitoring, 14(2), 1992, pp. 132-134
Risultati: 1-16 |